Health ❯ Healthcare ❯ Medical Research

Neurology

Alzheimer's Disease Dementia Parkinson's Disease Epilepsy Multiple Sclerosis Stroke Amyotrophic Lateral Sclerosis Migraine Treatment Biomarkers Neurodegenerative Diseases Chronic Traumatic Encephalopathy Cognitive Motor Dissociation ALS Treatment Migraine Sturge-Weber Syndrome Traumatic Brain Injury Huntington's Disease Stroke Treatment Idiopathic Normal Pressure Hydrocephalus Spinal Cord Injuries Protein Accumulation Spinal Cord Injury Idiopathic Intracranial Hypertension Dementia Awareness Tauopathies Stroke Recovery Brain Tumors Rare Diseases Post-Herpetic Neuralgia Subacute Sclerosing Panencephalitis Tourette Syndrome Stroke and Brain Injury

Journal Review Highlights Ecopipam as a Non‑Antipsychotic Option for Pediatric Tourette

Selective D1 blockade is linked to lower tic relapse with fewer antipsychotic side effects during Teva’s expedited FDA review.

Low-Dose Rapamycin Raises Brain Blood Flow in APOE4 Carriers

Stroke Remodels Brain Microenvironment to Drive Glioma Growth

Wide Plasma Proteomics Study Finds Distinct Blood Signals for Amyloid Clearance and Cognitive Change in Patients on Lecanemab

FDA Clears PrecivityAD2 Blood Test for Symptomatic Adults Aged 40 and Up

Estrogen-Only Menopausal Therapy Linked to Fewer Alzheimer’s Markers on Autopsy

New Blood Biomarkers Differentiate Alzheimer’s Risk by Disease Stage

Blood p‑tau217 Test Predicts Elevated 5‑ and 10‑Year Alzheimer’s Risk

Blood Test p‑tau217 Predicts Alzheimer Risk but Not Ready for Routine Screening

Biogen's Tau Drug Cuts Brain Tau but Misses Dose‑Response Goal

34‑circRNA Blood Signature Outperforms pTau217 in Detecting and Predicting Alzheimer’s

Brockman Family Donates $110 Million to Houston Methodist, New Tower to Carry Their Name

Copper Compound Restores Brain Clearance Pump and Cuts Alzheimer’s Proteins in Mice

Glucosamine Linked to Faster Dementia Progression and Higher Death Risk, Study Finds

Glucosamine Linked to Faster Progression and Higher Death Rates in Alzheimer’s Patients

Blood Tests and New PET Tracer Reveal Early Alzheimer’s Signals in Some Middle‑Aged Adults

Migraine CGRP Drugs Tied to Lower Glaucoma Risk in Neurology Study

Mayo Clinic Study Finds Autism Far More Common in Children With Epilepsy

Common Blood Test Marker Linked to Higher Future Dementia Risk, Large Study Finds

Major Review Says New Alzheimer’s Antibodies Offer No Meaningful Benefit